Cyclops®

Cannovex and PureIMS Announce Strategic Co-Development Agreement for Inhaled Cannabinoid Pharmaceuticals

Month: March 2026

Cannovex and PureIMS Announce Strategic Co-Development Agreement for Inhaled Cannabinoid Pharmaceuticals

Cannovex and PureIMS Announce Strategic Co-Development Agreement for Inhaled Cannabinoid Pharmaceuticals

Download a copy of this press release here. Diepenbeek, Belgium and Roden, The Netherlands, March 13, 2026 – Cannovex and PureIMS have entered into a strategic partnership to develop innovative pharmaceutical cannabinoid products. The collaboration combines Cannovex’s proprietary cannabinoid formulations with PureIMS’s patented Cyclops® dry powder inhaler (DPI). Under the terms of the agreement, Cannovex […]